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ABSTRACT
THE EXPRESSION OF CONNEXIN-43 BY CD11c+ DENDRITIC CELLS IS REQUIRED TO
MAINTAIN CD4+ Foxp3+ REGULATORY T CELL POPULATION IN PERIPHERAL
LYMPHOID ORGANS
Caroline Titus Miller
Old Dominion University, 2019
Director: Dr. Piotr J. Kraj

Foxp3+ regulatory T cells (TR) are an immunosuppressive subset of CD4+ T cells that maintain
homeostasis of the immune system. They are sustained by the interaction between the Major
Histocompatibility Complex (MHC) molecules present on antigen presenting dendritic cells and
the T Cell Receptor (TCR) expressed on TR cells that is specific for the MHC loaded with an
antigenic peptide. Here, we show that in addition to MHC/TCR interaction, Connexin-43 (Cx43)
expression by dendritic cells is required to maintain the TR cell population. CD11c+ dendritic cells
represent a major subset of antigen presenting cells. Using flow cytometry, we have observed that
mice which lack Cx43 expression in CD11c+ dendritic cells (Cx43DC-), have a lower percentage of
TR cells which express lower levels of Foxp3. These mice showed increased incidence of
dermatitis as they age, even though we show that their dendritic cells can efficiently present antigen
to naive T cells using proliferation inhibition assay. The decrease in the proportion of TR cells were
associated with an altered phenotype of these cells, demonstrated by lower expression of CD39
and higher expression of CD73, ectonucleotidases mediating TR cell immunosuppressive function.
We propose that the presence of Cx43 on the surface of dendritic cells is required for effective
communication between TR cells and dendritic cells so as to sustain TR cell homeostatic expansion
and Foxp3 expression.
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H

Tritium

AMP

Adenosine MonoPhosphate

ADP

Adenosine DiPhosphate

ATP

Adenosine TriPhosphate

APC

Antigen Presenting Cell

BCR

B cell receptor

cAMP

cyclic Adenosine MonoPhosphate

CFA

Complete Freund’s Adjuvant

CTLA-4

Cytotoxic T lymphocyte Antigen-4

CTM

Complete Tumor Medium

Cx

Connexin

CXCL8

C-X-C motif Ligand 8

DC

Dendritic Cell

DNA

DeoxyriboNucleic Acid

FBS

Fetal Bovine Serum

FGL2

Fibrinogen-like protein

Foxp3

Forkhead-box P3

IL

Interleukin

Klrg1

Killer cell Lectin like Receptor G1

LAG-3

Lymphocyte-Activation Gene-3

MHCI

Major Histocompatibility Complex Class I
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MHCII

Major Histocompatibility Complex Class II

min

Minute (s)

NAD

Nicotinamide Adenine Dinucleotide

PBS

Phosphate Buffered Solution

PD1

Programmed cell Death protein 1

PE

Phycoerythrin

rpm

Revolutions per minute

TCR

T-Cell Receptor

TGF-β

Tumor Growth Factor β

TH1

T helper 1

TH2

T helper 2

TH17

T helper 17

TNF

Tumor Necrosis Factor

TR cells

Regulatory T cells

TRAIL-DR5 Tumor-necrosis-factor Related Apoptosis-Inducing Ligand-Death Receptor 5
WT

Wild-Type
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CHAPTER 1
INTRODUCTION

Most multi-cellular organisms, if not all, face the constant threat of infection by a variety of
microbial pathogens. The probability that the host organism will survive depends on its ability to
overpower and eliminate the invading foreign material, by inducing defensive responses that are
termed broadly as ‘immune responses’. Ideally, these responses target the pathogenic material and
not the host cells and tissues. In this introduction, we will review antigen presentation by innate
immune cells and the consequent activation of a few specific types of T cell subsets that play an
important role in adaptive immunity and homeostasis. In addition, we will discuss the current
understanding of the role of Connexin-43 in the immunological synapse, and how it relates to
current research.

1.1. Antigen presentation
The first line of defense against foreign material is the physical and chemical barriers of the body
like skin and antimicrobial enzymes secreted at mucosal surfaces, respectively. If foreign material
or a pathogen were to successfully overcome the barriers and enter the body, the innate immune
system responds to it in a multi-faceted way. Neutrophils, basophils, macrophages, monocytes,
dendritic cells, natural killer cells and granulocytes bind foreign molecules through Pattern
Recognition Receptors (PRRs), get activated and directly or indirectly facilitate the elimination of
the pathogen (1-3). In most cases, the pathogen or what is referred to as antigen, is digested and
destroyed by resident phagocytes. All phagocytic cells like macrophages/monocytes, granulocytes
and dendritic cells have the ability to internalize antigen, through a process called phagocytosis,
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or take up large amounts of extracellular material through a process called pinocytosis and degrade
the antigens that were endocytosed. Activated phagocytes secrete pro-inflammatory cytokines like
Tumor Necrosis Factor-α (TNF-α), Interleukin-1 (IL-1), IL-6 and IL-18 and chemokines like
CXCL-8 that recruit and activate cells of the adaptive immune system at the site of pathogen entry
(4, 5).
One of the main roles of phagocytes is to present antigenic peptides on the cell's surface in order
to activate cytotoxic and helper T cells of the adaptive immune system. T cells are not able to
recognize native antigens and conformational epitopes; therefore, they depend on recognition of
processed antigen for activation. Antigen processing relies on proteolytic digestion of ingested
proteins/antigens and binding of resulting peptides to the Major Histocompatibility Complex
(MHC) molecules. MHCs are polymorphic transmembrane glycoproteins found on the cell's
surface having a characteristic peptide-binding groove. MHC structure is stabilized by binding
peptides derived from self or exogenous proteins. There are two types of MHC molecules. MHC
Class I (MHCI) molecules are expressed by all nucleated cells and present antigenic peptides to
cytotoxic CD8+ T cells (6). It increases the targeting of abnormal cells by CD8+ cytotoxic T cells
that recognizes the mutated peptides, like those resulting from DNA damage or cancer associated
mutations (7). MHC Class II molecules are only present on phagocytic cells, of which
macrophages and dendritic cells are referred to as "professional antigen presenting cells" (8). When
the endocytosed material is broken down in acidified endosomes, it is loaded onto the MHCII
molecule and transported to the cell membrane for antigen presentation. The helper CD4+ T cells
require this presentation of antigenic peptide in the context of MHCII molecules in order to be
activated (9). CD11c is a type I transmembrane protein that is constitutively present on all dendritic
cells and is used in conjunction with other markers to identify various subsets. CD11c is, therefore,
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used in this study to identify the dendritic cell population, which are known to be efficient
activators of regulatory T cell population. This is further discussed in 1.3.

1.2. Development and activation of CD4+ T cells
The adaptive immune responses are carried out by B and T lymphocytes, two types of white blood
cells that are differentiated from hematopoietic stem cells in the bone marrow. B cell
differentiation occurs in the bone marrow, and T cell maturation takes place in the thymus. B cells
and T cells have a large repertoire of B cell receptors (BCRs) or T cell receptors (TCRs) to enable
these cell types to detect and eliminate a variety of pathogens (10). A TCR is a dimer and consists
of one α and one β chain, each having a variable and a constant region. The variable regions of
these chains have a unique sequence that can bind to a peptide in complex with an MHC molecule.
In this way, T cells are MHC-restricted and cannot be activated by antigenic peptide alone. The
development of T cells or thymocytes takes place in the thymus and is a very systematic process
that ensures a low probability of self-reactivity. After the successful rearrangements of the V, D
and J gene segments of the TCR’s β-chain takes place, there is a rapid clonal expansion of the cells
whose β-chain was successfully rearranged, accompanied by the expression of co-receptor proteins
CD4 and CD8 that have the role of binding to a portion of the MHC Class II and MHC Class I
molecule, respectively, to infer stability of the eventual TCR/MHC interaction (11, 12). The cell
proliferation is followed by α-chain rearrangement in each individual cell (13). The next step in
ensuring that these cells will bind to an MHC molecule is called positive selection where thymic
cortical epithelial cells express MHC molecules for thymocytes to bind, and during this step, the
T cell will commit to expressing either CD4 or CD8 depending on the strength of the affinity by
which the TCR binds to the MHCII or MHCI (14). In addition, the T cells that do not bind in this
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step undergo apoptosis. During negative selection, any thymocyte that binds with high affinity to
an MHC molecule with a self-antigen peptide is eliminated by apoptosis (15). This significantly
reduces the chance of auto-reactive T cell clones. Elimination of self-reactive T cells is
complemented by a dominant tolerance mechanism relying on the presence of suppressor CD4+ T
cells. These cells, called natural regulatory T cells (TR), expressing transcription factor Forkhead
box P3 (Foxp3) are generated in the thymus and recognize MHCII + self-peptides. Current data
support the conclusion that TR cells are generated in an instructive process when interactions
between TCR and MHCII/peptide complex, stronger than that of conventional CD4+ thymocytes,
induce Foxp3 expression and launch a genetic program of TR cell differentiation (16).
Immunosuppressive role of TR cells relies on various mechanisms and depends on recognition of
a self-peptide on MHCII molecule, which is further discussed in 1.3. The CD4+ Foxp3+ TR
thymocytes migrate out of the thymus and circulate to the lymphoid tissues through the blood
stream. Professional antigen presenting cells like dendritic cells migrate to the lymphoid tissues to
interact with circulating naïve CD4+ conventional and TR cells (17). These could be CD11c+
migratory Langerhans cells or dermal dendritic cells that reside in the skin and sample antigens
(18). When the naïve CD4+ T helper cell recognizes the specific antigen presented by a dendritic
cell and co-stimulatory molecules, the T cell remains in the lymphoid tissue and undergoes clonal
expansion with the production of cytokines that gives rise to effector T cells and memory T cells.
The naïve and effector T cells migrate out of the lymph node and move toward the site of infection
by chemotaxis. The CD4+ T cells recognize antigen presented by APC at the site of infection, get
activated and undergo clonal expansion and cytokine production (19). Depending on the cytokines
in the environment, the effector T cells differentiate into subsets like T helper 1 (TH1) cells that
secrete IFN-γ (20), T helper 2 (TH2) cells that secrete IL-4 (21), T helper 17 (TH17) cells that
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secrete IL-17 (22) or peripheral regulatory T (TR) cells that secrete IL-10, as depicted in Fig. 1
(23), and upregulate the expression of characteristic transcription factors and cytokines. TH1, TH2
and TH17 cells release pro-inflammatory cytokines, whereas TR performs an immunosuppressive
role and controls the immune response (22).

Fig. 1. Naïve T cells differentiate on activation based on the cytokines in its environment.
Animated drawing depicting TCR/MHC interaction between an APC and CD4+ T cell through
MHC-II; and interaction between the APC and CD8+ T cell through MHC-I. Based on the
cytokines in the environment, the effector T cells differentiate into effector cells with proinflammatory, anti-inflammatory or cytotoxic roles specified within the orange boxes. The yellow
boxes note the genes that are upregulated in the T cell subset. (23).
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1.3. Immunosuppressive CD4+ Foxp3+ regulatory T cells
Maintenance of immune tolerance is largely carried out by CD4+ Foxp3+ TR cells. Gene mapping
and functional studies established that Foxp3 is an X-chromosome-encoded gene and a master
regulator of CD4+ TR cell development in both humans and mice. Foxp3-deficient mice do not
have functional TR cell population and develop fatal lymphoproliferative autoimmune syndrome
at 3-4 weeks of age (24). TR cells constitute up to 10-20% of the CD4+ T cell compartment. Like
other CD4+ T cells, CD4+ Foxp3+ TR cell population’s development and activation are strictly
dependent on the TCR/MHC interactions (25).
All APCs, expressing class II MHC molecules, have the ability to induce antigen specific CD4 +
Foxp3+ TR cells in the presence of IL-2 and TGF-β. However, there is evidence that dendritic cells
(DCs) are the most efficient activators of TR cells (26). In the presence of high concentrations of
IL-2, the apoptotic signaling in TR cells is inhibited. On recognition of the MHC/peptide
complexes through their TCR, TR cells undergo clonal expansion and make direct contact or
produce effector molecules to enforce immune suppression. Some of the molecules by which these
TR cells maintain homeostasis have been outlined in Table 1 (27). Foxp3+ Regulatory T cells can
be immunosuppressive in an antigen non-specific manner in multiple ways. Through the secretion
of cytokines like TGF-β and IL-35 by TR cells, CD4+ effector cells are led to differentiate into
immunosuppressive Foxp3+ cells as discussed in 1.2 (28, 29). Other cytokines like IL-10 have
been shown to be required for effective immunosuppression at interfaces like the colon and lungs
(30). Regulatory T cells are also able to transfer cyclic-AMP (cAMP) into conventional cells in a
contact-dependent manner through gap junctions to result in the induction of the expression of the
transcription factor ICER (Induced Cyclic-AMP Early Repressor) in conventional CD4+ T cells.
ICER represses at the IL-2 and IL-4 gene loci and prevents the secretion of cytokines by the
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activated CD4+ T cells (31). CD39 is an ectonucleotidase present on the surface of Foxp3+ TR
cells, that converts adenosine diphosphate (ADP) or adenosine triphosphate (ATP) to adenosine
monophosphate (AMP), where ATP is a known mediator of inflammation. CD73 is also an
ectonucleotidase on the TR cell whose function complements CD39 and converts AMP to
adenosine which has been shown to have an immunosuppressive role (32). TR cells can also
maintain homeostasis by secreting cytolytic molecules like granzymes and perforin to induce
apoptosis in conventional CD4+ T cells (33). Certain dendritic cells express indoleamine 2,3dioxygenase (IDO) that catalyzes the degradation of tryptophan to kynurenine which starves the
effector T cells and puts them in cell cycle arrest. Via CTLA-4-induced signaling, TR cells can
increase IDO expression in dendritic cells and also direct TR differentiation of naïve CD4+ T cells
(34).

Table 1. Immunosuppressive effector molecules of TR cells. The known effector molecules of
TR cells can be classified into secreted immunosuppressive cytokine molecules, molecules that
inhibit metabolic signaling, secreted cytolytic molecules and membrane associated molecules that
inhibit T effector cell activation.
IL- interleukin; TGF-β- Tumor growth factor β; FGL2- Fibrinogen-like protein; cAMP-inhibitory
second messenger cyclic AMP; NAD- nicotinamide adenine dinucleotide as metabolized by CD38
and operative at P2X7; TRAIL-DR5 (tumor-necrosis-factor-related apoptosis-inducing liganddeath receptor 5); CTLA-4- Cytotoxic T-Lymphocyte Antigen 4; LAG-3- Lymphocyte-activation
gene 3 (27).
Immunosuppressive
cytokines

Metabolic
signaling

Cytolytic
molecules

Membraneassociated molecules

TGF-β
IL-10
IL-35
FGL2

cAMP
CD39
CD73
NAD

Granzyme A/B
Perforin
TRAIL-DR5
Galectin-1

CTLA-4
LAG-3
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As a result of the effects of these molecules and direct interactions, activated T cells and antigen
presenting cells are not able to carry out their immunological response effectively. TR cell
population consumes a large portion of IL-2 produced by the activated CD4+ T cells and in doing
so, carries out IL-2 deprivation and induces apoptosis of both cell populations (35). For this reason,
TR cell populations were initially identified by the expression of CD25, which is the α-chain of the
IL-2 receptor. However, the upregulation of CD25 on all activated CD4+ cells and the existence
of non-immunosuppressive CD4+ CD25+ cells were observed, and Foxp3 expression was found to
be a more precise marker for the immunosuppressive cells (24). Immunoregulation is an essential
process in order to avoid potentially damaging autoimmune responses by non-regulatory T cells
and to maintain tolerance to self-antigens. CD4+ Foxp3+ TR cells have a high turnover rate and
respond to a range of signals from the environment that may make them anergic or persist as
memory cells (36). Therefore, maintenance of a stable population size of functional TR is required
for effective immune suppression.

1.4. Connexin-43
Connexins are a family of small transmembrane proteins that assemble into membrane complexes
to create small channels called gap junctions in order to allow communication between cells or
carry out paracrine functions as hemi-channels (37, 38). Connexin-43 (Cx43) has a relatively long
cytoplasmic domain with a number of phosphorylation sites that have been proposed to interact
with cytoskeletal elements and signaling molecules like protein kinase C, mitogen-activated
protein kinase and β-catenin (39). Recent evidence has shown that Cx43 may have the ability to
act as a transcription factor (40). The expression of Cx43 is widespread among immunological
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cells like dendritic cells, monocytes, B cells, T cells and Natural Killer cells (41). On antigen
activation, expression of Cx43 is upregulated in T cells (42). Hemi-channel function of Cx43 is
pro-inflammatory as it involves the release of ATP, a mediator of inflammation (43). In contrast,
channels can form at gap junctions between effector and TR cells to facilitate the transfer of cAMP
from TR cells to effector cells (31). In summary, modulating connexin-43 expression or gap
junction formation may alter the course of adaptive immune response mediated by T cells. When
the hemi-channel activity of Cx43 was reduced while simultaneously promoting gap junction
plaque formation using a mimetic peptide- αCT1 in a non-obese diabetic mouse model, TR
suppressor ability was partially restored (44). Phase III clinical trials of the use of αCT1 for wound
healing during treatment of diabetic foot ulcers is currently underway (45). Additionally, higher
expression of Cx43 has been observed in human and murine thymic epithelial cells (42). Although
the mechanism of its function has not been elucidated, several reports conclude that Cx43 is a
component of the immunological synapse.

1.5. Purpose of research and experimental design
To examine the role of gap junctions and communication between TR cells and DCs, we used a
mouse model in which Gja1 gene that codes for Cx43 was knocked out in CD11c+ dendritic cells
alone. Several of these mice spontaneously developed dermatitis and a preliminary experiment
showed a reduction in the number of CD4+ Foxp3+ TR cells in both the lymph nodes and spleens
of the Cx43DC- mice. This provided the initial motivation for the study of the role of connexin in
maintaining the regulatory T cell population. This research contributes to the literature on the
involvement of Cx43 in the maintenance of regulatory T cell population, with the hope of shedding
light on novel targets for therapeutic treatments of auto-immune diseases. We look into the changes
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caused in mice due to the lack of expression of Cx43 in dendritic cells. For this reason, phenotypic
and functional analyses of peripheral populations of DC and CD4+ T cells using flow cytometry
were carried out. Flow cytometry data on the dendritic cell population in the skin of wild-type
(WT) control mice and Cx43DC- mice were also analyzed. The ability of the CD11c+ dendritic cells
with no expression of Cx43 to activate CD4+ naïve T cells and the ability of their TR cells to
suppress proliferation of activated CD4+ T cells were measured through radioactive thymidine
incorporation assays described in 2.6. and 2.7.
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CHAPTER 2
METHODS

2.1. Generation of Cx43DC- mice
Conditional knockout of Gja1 gene that codes for Connexin-43 (Cx43loxP) were crossed with
CD11ccre and Foxp3GFP reporter mice (39, 46). These mice were compared to wild-type control
mice during analyses. Mice were housed and sacrificed according to the guidelines of the
Institutional Animal Care and Use Committee of Old Dominion University under IACUC protocol
number 17-017. Subsequent cell work was carried out with the approval of the Institutional
Biosafety Committee of Old Dominion University under IBC protocol number 19-007.

2.2. Isolation of dendritic cells from the skin
Dorsal skin from the mice were cut and incubated in 0.5 mL of 0.2 mg/mL Dispase I solution in a
24-well plate overnight at 4oC. Hair was removed and incubated at 37oC in 1 mL Collagenase IVDNase solution (RPMI, 10% FBS, 1.5 mg/mL Collagenase IV and 0.5 mg/mL DNase) followed
by addition of 1mL of Collagenase IV-DNase solution every 30 minutes for 2 hours. The solution
was then filtered and centrifuged at 1200 rpm for 6 minutes. The pellet was resuspended in PBS +
2% FBS for antibody staining and subsequent flow cytometry analysis.

2.3. Cell purification, flow cytometry and cell sorting
Lymph nodes and spleens of Cx43DC- and WT mice were isolated and passed through nylon mesh
to form cell suspensions in PBS + 2% FBS. Spleen suspensions were centrifuged at 1200 rpm for
6 minutes and resuspended with 0.16 M sterile ammonium chloride to lyse red blood cells in the
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sample. This sample was incubated at room temperature for 6 minutes and centrifuged at 1200
rpm and resuspended in PBS + 2% FBS. Aliquots of the cell suspension were stained with eight
color antibody sets with antibodies specific for CD4, CD8, CD44, CD62L, 4-1BB, Tim-3, PD-1,
IL-7R,Klrg-1, BTLA, Lag3, CD25, CD39, CD73, Sirp1α, CD80, 4-1BBL, MHCII, CD24, CD86,
PDL1, F4/80, Ox40L and Gr1 (BD Bioscience, BioLegend, eBioscience) for 30 minutes at 4 oC
with subsequent washes with PBS + 2% FBS, and analyzed using a flow cytometer
(BDFACSCanto). CD4+ cells were negatively selected using streptavidin beads (mentioned in 2.4),
while CD11c+ cells were positively selected using PE magnetic beads (mentioned in 2.5). In
addition to this, these cells were sorted from the cell suspensions using a flow cytometer (BD
Influx) for increased purity of 98-99%.

2.4. Negative selection of CD4+ cells using streptavidin beads.
Cell pellets were resuspended in 150 L of PBS + 2% FBS and stained with biotinylated antibodies
against CD8, Ter119, B220, CD49b (BD Bioscience, BioLegend, eBioscience) for 30 minutes at
4oC. After a wash with PBS+ 2%FBS, the cells were incubated with streptavidin magnetic beads
(Appendix) for 20 minutes at 4oC, and the tube was placed in a magnet for 6 minutes. The clear
solution was carefully pipetted out, centrifuged at 1200 rpm for 6 minutes and resuspended in PBS
+ 2% FBS as a CD4+ sample. Purity of the sample was checked using flow cytometry.

2.5. Positive selection of CD11c+ cells using PE beads.
Cell pellets were resuspended in 150 L of PBS + 2% FBS and stained with CD11c-PE antibody
for 30 minutes at 4oC, followed by a wash with PBS + 2% FBS. The cells were incubated with PE
beads for 20 minutes at 4oC. Then the cells were washed and resuspended in 750 L of PBS + 2
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% FBS and loaded into the column attached on a magnetic plane. The flow through was disposed,
and the column was detached from the magnet. PBS + 2% FBS was used to flush the CD11c+ cells
into a collection tube. Purity of the sample was checked by flow cytometry.

2.6. Proliferation assay
In a 96-well round bottomed plate, 3x104 sorted CD11c+ DCs and 2x104 CD4+ cells from a
transgenic mouse whose CD4+ T cells are specific for a peptide PCC50V54A were stimulated with
soluble peptide (5 M) in CTM (Appendix) and incubated at 37oC with 5% CO2. Three days after
stimulation, 1 Ci/well of 3H-thymidine was supplied. The radioactivity of the resulting cells after
washing were measured on Tri-Carb 3110TR Liquid Scintillation Analyzer.

2.7. Proliferation inhibition assay
In a 96-well round bottomed plate, 5x104 sorted naïve (CD44lo CD62Lhi) CD4+ T cells and 5x104
WT DCs from lymphopenic mice (TCRα-) were stimulated using antibody against CD3 (BD
Bioscience- 3 g/mL) in CTM (Appendix) and incubated at 37oC with 5% CO2. In different wells,
TR were added in increasing concentrations of 0%, 5%, 10% 20% and 40% of total naïve CD4+ T
cells. After three days of stimulation, 1 Ci/well of 3H-thymidine was added, and radioactivity of
the sample after washing was measured on Tri-Carb 3110TR Liquid Scintillation Analyzer.

2.8. Data analysis
Flow Cytometry data was analyzed in dot plots and histograms using FlowJo v10. The results of
the proliferation assay and the proliferation inhibition assay were graphed using Exel.
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CHAPTER 3
RESULTS

3.1. Development of dermatitis in Cx43DC- mouse
The Cx43DC- mice, having a lack of expression of Connexin-43 in CD11c+ dendritic cells, seem to
visually develop normally apart from the dermatitis observed. About 25% of mice aged 1 to 4
months begin to develop a form of dermatitis on their dorsal skin (Fig. 2), which is first seen as
barbering. Moreover, 60% of the mice older than 5 months had dermatitis progressing from
barbering to open skin lesions. This skin disease is likely caused by an autoimmune response that
has been sustained due to lack of immune suppression. During an auto-immune response, the TR
population is usually lower than in healthy mice. Lymph nodes and spleens were isolated from
these mice and T cell populations were analyzed to further investigate the cell populations affected
by the lack Cx43 in DCs that may have caused the disease.

Fig. 2. Cx43DC- mice spontaneously develop dermatitis. Image of barbering seen on the dorsal skin
of two-month old Cx43DC- mice
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3.2. Dendritic cell population density in the skin of Cx43DC- mice varies compared to that of wildtype control mice
To investigate the changes in skin’s dendritic cell population due to the lack of Cx43 on CD11c+
DC cells, skin was digested, and the cells were isolated to be stained. There was a presence of
CD11c+ MHCII+ CD24- CD103- dermal DCs in young 2-month old Cx43DC- mice, which was
barely detectable in control mice (Fig. 3). These cells are usually only detectable at 3 months of
age as the immune system matures. It is possible that the existence of larger proportion of dermal
dendritic cells that are migrating to the skin, is the reason why Cx43DC- mice are predisposed to
developing skin disease. The CD11c+ MHCII+ CD24+ CD11b+ Langerhans cell population was
increased in Cx43DC- mice with respect to age, whereas CD11c+ MHCII+ CD24+ CD11b- dermal
dendritic cell population was decreased, also with respect to age compared with age-matched WT
mice older than 3 months.
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Fig. 3. Increased presence of dermal dendritic cells in the dorsal skin of 2 month old Cx43DC- mice.
Mice lacking Cx43 expression by CD11c+ dendritic cells have a larger proportion of CD24CD103- dermal dendritic cells in the dorsal skin of 2 month old mice. Dermal dendritic cells usually
are present in low numbers in the skin till 3 months of age when the immune system is mature.

3.3. Increased activation is seen in older Cx43DC- mice with dermatitis.
The flow cytometry data analysis of cells from lymph nodes showed that in Cx43 DC- mice with
dermatitis, more than 70% of the CD4+ cells in the lymph nodes were activated, depicted as
CD44hiCD62lo cell population in Fig. 4. These activated cells from Cx43DC- mice had a decrease
in activation markers 4-1BB and Klrg1 expression, accompanied by an increase in inhibitory
molecule PD-1 in old mice, compared to age-matched WT (Fig. 5). The changes in population of
activated cells and expression of activation markers shown in Fig. 4 and 5 were not seen in Cx43DCmice without dermatitis or in the WT mice. Therefore, the increased activated population could be
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attributed to the response to the dermatitis seen on the dorsal skin, while the changes in expression
of 4-1BB and Klrg1 may be due to the way Cx43DC- cell populations interact after the onset
dermatitis.

Fig. 4. Increased activation in Cx43DC- mice with dermatitis. Total CD4+ cells can be separated
into activated and naïve cells based on the expression of CD44 and CD62L. The plots show that
old Cx43DC- mice with dermatitis had almost 80% of CD4+ cells activated in the lymph nodes.
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Fig. 5. Changes in expression of molecular markers for activation and inhibition in activated cells
of Cx43DC-. Histograms showing the expression of 4-1BB, PD-1, IL-7R, Klrg1, Lag3 and BTLA
by activated CD4+ CD44hiCD62lo cells of WT and Cx43DC- mice.

3.4. Decrease of CD4+ Foxp3+ TR population in Cx43DC- mice with relation to age.
Using flow cytometry, we analyzed the different T cell populations in the lymph nodes of the
knockout mice alongside age-matched controls. We found that Cx43DC- mice had a smaller
population of CD4+ Foxp3+ TR cells compared to WT mice (Fig. 6, 7). Additionally, these TR cells
expressed Foxp3 with a lesser intensity (Fig. 8) as indicated by the decrease in mean fluorescence
intensity measurement of the fluorophore by flow cytometry. The lower amounts of
immunosuppressive regulatory T cells may have led to the development of dermatitis seen among
Cx43DC- mice, due to the consequent failure to control immune response at the dorsal skin.
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Fig. 6. Lower CD4+ Foxp3+ TR cell population in Cx43DC- mice. Flow cytometry analysis of Foxp3
expression by gated CD4+ Foxp3+ cells showing that Cx43DC- mice had lower proportion of Foxp3+
TR cells compared to age-matched WT at 2 months, 9 months and 12 months.

● WT
○ Cx43DC-

Fig. 7. Decrease in CD4+ Foxp3+ TR population in Cx43DC- mice with respect to age. The
percentage of TR cells in lymph nodes of Cx43DC- mice decrease with respect to age categorized
as 1-3 months, 4-7 months and greater than 8 months, based on flow cytometry data.
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● WT
○ Cx43DC-

Fig. 8. Decrease in Foxp3 expression of CD4+ Foxp3+ TR cells in Cx43DC- mice with respect to
age. Mean fluorescence Intensity of Foxp3 expression of the TR cells of Cx43DC- mice is also
reduced, portraying a reduced expression of Foxp3 at 1-3 months of age and greater than 8 months
of age based on flow cytometry data.

3.5. An altered phenotype of CD4+ Foxp3+ TR is observed in Cx43DC- mice.
As mentioned earlier, CD39 and CD73 are ectonucleotidases on the surface of Foxp3+ regulatory
T cells. Flow cytometric data analysis of Foxp3+ TR cells of Cx43DC- mice showed that a large
majority of the cells took on a CD39+ CD73+ phenotype (Fig. 9), unlike the populations of different
level of expressions seen in WT mice. This population also had a decrease in CD39 expression
and an increase in CD73 expression compared to the same population of WT mice (Fig. 10).
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Fig. 9. Majority of CD4+ Foxp3+ cells of Cx43DC- mice have acquired CD39+ CD73+ phenotype.
Flow cytometry data that shows that more than 90% of CD4+ Foxp3+ TR cells from Cx43DC- mice
have acquired CD39+ CD73+ phenotype at young (2 months) and old (12 months) age compared
to age-matched WT.
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Fig. 10. CD4+ Foxp3+ TR cells of Cx43DC- mice have altered expression of CD39 and CD73. The
CD4+ Foxp3+ CD39+ CD73+ TR population gated in Fig. 7 displays varied expressions of CD39
and CD73 among Cx43DC- and WT. There is reduced expression of CD39 and increased expression
of CD73, measured by flow cytometry in both young and old mice.

3.6. CD4+ Foxp3+ TR cells from Cx43DC- mice suppress the proliferation of CD4+ cells.
It was proposed that presence of CD4+ Foxp3+ CD39+ CD73+ with altered phenotype might offset the conversion of pro-inflammatory ATP to immunosuppressive adenosine and be responsible
for a possible lack of immune suppression leading to the dermatitis seen on the mice. To check
this, we set up a proliferation inhibition assay with APCs and CD4+ naïve T cells along with
increasing proportions of CD4+ Foxp3+ TR cells. The splenocytes were taken from TCRKO mice
which did not have functioning T cells, and used as APCs in this assay. Soluble CD3 antibody was
supplied to ensure activation of the CD4+ naïve T cells. The amount of tritium labelled thymidine
(3H-thymidine) incorporated was used to measure proliferation of the cells. The results from this
experiment show that the CD4+ Foxp3+ cells from the Cx43DC- mice suppressed the proliferation
of CD4+ naïve WT cells at a comparable level as CD4+ Foxp3+ cells from WT mice, with only a
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slight decrease, as the readings were within one standard deviation of the WT and considered not
significant (Fig. 11). Although the phenotype of the regulatory cells developed in Cx43DC- mice
had altered levels of CD39 and CD73 expression, perhaps they were able to suppress using
mechanisms of immunosuppression.

Fig. 11. Proliferation inhibition assay results. Data from the scintillation counter showing the
proliferation of CD4+ T cells on activation decreases when CD4+ Foxp3+ TR cells are added to the
well.

3.7. Prominent CD4+ Foxp3- CD25+ cell population is seen in Cx43DC- mice
Flow cytometry analysis showed that WT mice have less than one percent of Foxp3- CD25+ cells
at 2 months and at 12 months, whereas Cx43DC- have about 4% at 2 months and about 10% when
they are 12 months or older (Fig. 12). CD25 is the IL-2 receptor required for differentiation into
CD4+ Foxp3+ TR cells in the presence of IL-2. There is a possibility that Foxp3+ cells lose their
Foxp3 expression while still expressing CD25 but are not immunosuppressive. Increased
population of CD25+Foxp3- cells is present in mice where TR cell ontogeny is disrupted by deletion

24
of connexin gene in double positive thymocytes. Increased proportion of this population in
Cx43DC- mice indicates that there is impaired communication between TR and DC cells that affects
TR cell stability in the peripheral tissues. Thus, transition of Foxp3+ cells to Foxp3- CD25+ cells
could be the cause for decreased proportion of CD4+ Foxp3+ TR population in Cx43DC- mice. Cx43
expression by dendritic cells may be involved in triggering CD4+ Foxp3+ T cells that do not lose
their Foxp3 expression.

Fig. 12. Prominent presence of CD4+ Foxp3- CD25+ cells in Cx43DC- mice. Age-matched WT and
Cx43DC- have differing proportions of CD4+ Foxp3- CD25+ cells shown by flow cytometry at
young (2 months) and old (12 months) age.

25
3.8. CD11c+ dendritic cells from Cx43DC- mice can present antigen effectively
CD11c+ dendritic cells sorted from WT or Cx43DC- mice were added to a well with CD4+ naïve T
cells sorted from a mouse with transgenic TCR for a peptide PCC50V54A in a proliferation assay.
After four days of incubation with the peptide, 3H-Thymidine was added. The incorporation of 3HThymidine was used to measure proliferation of CD4+ that were successfully activated by CD11c+
dendritic cells. Fig. 13 shows that CD4+ T cells activated by DCs from Cx43DC- mice proliferate
more vigorously than the same cells activated by wild type dendritic cells. This data shows that
inhibition of communication between TR cells and DCs also affect DCs by making them more
effective antigen presenting cells. This further suggests that TR cells modulate antigen presenting
cells. Enhanced function of antigen presenting cells in Cx43DC- mice likely affects organs which
are exposed to contact with environment like skin and gut airways. Enhanced responses to antigen
could be a factor that promotes the skin inflammation observed in Cx43DC- mice. In the current
assay, this could result in the enhanced proliferation of effector CD4+ T cells.

350000

3H-Thymidine

300000
250000
200000
150000
100000
50000
0
WT

Cx43DC-

Fig. 13. Proliferation assay results. Data from the proliferation assay with CD11c+ APCs from WT
and Cx43DC- mice with CD4+ T cells from transgenic mice specific for peptide PCC50V54A. 3HThymidine measurements show that CD11c+ DC from Cx43DC- triggered greater proliferation.
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CHAPTER 4
DISCUSSION

4.1. Cx43 expression by CD11c+ dendritic cells maintains CD4+ Foxp3+ cell population
Lack of Cx43 expression in CD11c+ dendritic cells alone resulted in decrease in population of
CD4+ Foxp3+ TR, and a possible formation of dermatitis on the dorsal skin of the mouse. These
findings support that of Yamazaki et al. (2003) in that it confirms that CD11c+ dendritic cells
maintain the TR population (26). However, our data shows that in addition to the interactions
between TCR on TR cells and MHC on DCs are important for both cell populations and that the
communications through gap junctions is most likely required for sustaining functions of both
cell subsets.
CD25 is the IL-2 receptor required for differentiation into TR cells. A prominent population of
CD4+ Foxp3- CD25+ cells were seen in the lymph nodes of Cx43DC- mice. An explanation could
be that the TR cells that were formed in the periphery during activation lose their Foxp3
expression and may assume features of exTR cells (47, 48). These cells are known to produce
pro-inflammatory cytokines and promote autoimmune diseases. It is currently not known what
promotes loss of Foxp3 and generation of exTR cells. It is possible that the loss of Foxp3 by TR
cells, and thereby its immunosuppressive function, is the reason for the increase in proliferation
seen in the proliferation assay where CD11c+ DC from Cx43DC- mice presented PCC50V54A
antigen to CD4+ naïve T cells. In case of TR cells that interacted with the peptide + MHCII on
CD11c+ DC that did not have Cx43 for proper signaling, TR cells may not receive some, at
present unknown, signal dependent on gap junction formation, leading to loss of Foxp3
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expression. At the same time, Cx43 deficient DCs also loose TR cell mediated tonic signal which
conditions these cells to be over-stimulatory. Overtime, lack of interactions between DCs and TR
cells which involve Cx43 affects both populations altering their response to homeostatic
interactions and antigenic stimulation.
We hypothesized that the CD4+ Foxp3+ TR cell from Cx43DC- mice were not able to suppress
proliferation due to the changes in CD39 and CD73 expression which may offset the conversion
of pro-inflammatory ATP to immunosuppressive adenosine. However, the results of the
proliferation inhibition assay show that these TR cells suppressed the proliferation of activated
CD4+ T cells with only a slight decrease in immunosuppressive function. However, the
proliferation inhibition assay used to examine the suppressor function of TR cells from Cx43DCmice may not be the most suitable assay. This was the first assay used to probe TR cell function
in vitro and there has been multiple examples when the short term suppressor function of TR cells
is preserved in vitro but in vivo functions are impaired.
Taken together, our results show that lack of Cx43 expression by dendritic cells does not affect
the ability of these cells to present antigen to CD4+ naïve T cells and activate them. However, the
CD4+ Foxp3+ population was significantly reduced. Knowing that dendritic cells maintain the TR
cell population (26) and that Cx43 signaling enhances the generation of Foxp3+ TR cells (39), we
propose that Cx43 expression by CD11c+ dendritic cells is required for maintaining CD4+
Foxp3+ TR cell population.
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4.2. Future Research
It is possible that CD11c+ DC interact with an intermediary component that directly or indirectly
maintain the TR cell population, but there is no evidence of such a component as of now. We
were not able to test the antigen-specific activation of regulatory T cells by antigen presenting
cells because TR cells with transgenic TCR do not make it through thymic selection. Thus, we
were unable to run an in vitro test of aspects of the interaction between APC and antigen specific
TR cells. The findings of a study like this would be of great importance to our proposal of the
role of Cx43.
Cx43 is undeniably a part of the immunological synapse and this has been proposed by multiple
research studies. The results of application of αCT1, a mimetic peptide of Cx43, to increase
wound healing mentioned earlier is a big example of this association. Our results implicate gap
junction protein, Cx43 in the communication between CD11c+ dendritic cells and CD4+ Foxp3+
TR cells. It is possible that Cx43 is used by CD4+ effector T cells or CD4+ Foxp3+ T cells to
execute their immunological roles and this could be a topic of interest for future research. In
addition, it is very likely that Cx43 is not the only connexin involved in maintaining regulatory T
cells. Furthermore, looking into the Cx43 signaling pathway may shed some light onto the
precise changes taking place at a molecular level that leads to maintenance of regulatory T cells.
Undeniably, understanding the cells that use or require Cx43 to directly or indirectly control
auto-immune responses will open up pathways for targeted therapies that may correct one of the
underlying factors of autoimmune diseases which is the low amount of CD4+ Foxp3+ TR at the
site of immune response.
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CHAPTER 5
CONCLUSION

In the Cx43DC- mouse model, Connexin-43 molecule is not expressed by CD11c+ dendritic cells
and a higher probability of developing dermatitis was seen in these mice. The low population of
TR in these mice, support the notion that the skin disease may be autoimmune in nature. The ability
of CD11c+ dendritic cells to present antigen to naïve T cells were not affected by the loss of Cx43.
However, the drastic decrease in TR cell population and Foxp3 expression, combined with the
altered CD39+ CD73+ phenotype, indicate that Cx43 is an important player in the communication
between antigen presenting cells and the TR cell subset. These results also suggest that TCR/MHC
interaction along with defined co-stimulatory processes are not enough in itself, but require Cx43
expression by CD11c dendritic cells, to maintain immunosuppressive CD4+ Foxp3+ TR cell
population in the peripheral lymph nodes.
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APPENDIX
REAGENTS
0.16M Ammonium Chloride
NH4Cl: 8.3g, KH3CO: 1g, MiliQ added up to 1L with pH at 7.2.

Antibody Stains (eBioscience, BD Bioscience, BioLegend)
Fluorophores

Antibodies for

APC
APC-Cy7
Biotinylated
BV421
BV510
FITC
PE
PE-Cy5
PE-Cy7

BTLA
CD4
CD8
CD8
CD4
MHCII
CD4
CXCR3
CD4

CD11c
CD8
CD39
CD25

Tim3
CD62L
CD49b

CD11c
IL-7R
PD1

CD44
CD4
Lag3

4-1BB

Klrg1

Ter119

CD73

BSS
NaCl 8g, KCl 400mg, CaCl2 140mg, MgSO4.7H20 100mg, MgCl2.6H2O 100mg,
Na2HPO4.2H2O 60mg, KH2PO4 60mg, Glucose 1g, NaHCO3 350mg, MiliQ added up to 1L.
Collagenase IV (Worthington)
Complete Freund’s Adjuvant (CFA) (Sigma-Aldrich)
Mixed with 1x PBS at 1:1 before administration
Complete Tumor Medium (CTM)
αMEM 500mL, “tumor cocktail” 50mL, FBS 50mL, L-glutamine (200mM) 5mL.
Tumor cocktail- αMEM 630mL, dextrose 7.5g, essential amino acids 50x (Cellgro) 200mL,
endogenic amino acids 100x (Cellgro) 100mL, Sodium pyruvate 100x (Cellgro) 100mL, adjust
pH to 7.0, NaHCO3 8.5g, Gentamycin (Gemini Bioproducts) 0.5g, Penicillin G 0.6g,
Streptomycin 1g, β-mercaptoethanol 34uL.
Dispase I (Sigma-Aldrich)
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DNase (Sigma-Aldrich)
FBS(Atlanta Biologicals)
Fetal Bovine Serum
1X PBS (Cellgro)
Dulbecco’s Phosphate Buffered Saline without calcium and magnesium
PE Magnetic beads (Miltenyi Biotec)

RPMI (HyClone)
Roswell Park Memorial Institute growth medium 1640 with L-Glutamine

Streptavidin Magnetic beads (BD Bioscience)
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